117 related articles for article (PubMed ID: 9664946)
1. Effect of diet and fluvastatin treatment on the serum lipid profile of kidney transplant, diabetic recipients: a 1-year follow up.
Földes K; Makláry E; Vargha P; Janssen J; Járay J; Perner F; Geró L
Transpl Int; 1998; 11 Suppl 1():S65-8. PubMed ID: 9664946
[TBL] [Abstract][Full Text] [Related]
2. Fluvastatin (Lescol) treatment of hyperlipidaemia in patients with renal transplants.
Löcsey L; Asztalos L; Kincses Z; Balázs G
Int Urol Nephrol; 1997; 29(1):95-106. PubMed ID: 9203045
[TBL] [Abstract][Full Text] [Related]
3. Effect of fluvastatin on lipoprotein profiles in treating renal transplant recipients with dyslipoproteinemia.
Li PK; Mak TW; Chan TH; Wang A; Lam CW; Lai KN
Transplantation; 1995 Oct; 60(7):652-6. PubMed ID: 7570971
[TBL] [Abstract][Full Text] [Related]
4. Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy.
Austen JL; Shifrin FA; Bartucci MR; Knauss TC; Schulak JA; Hricik DE
Ann Pharmacother; 1996 Dec; 30(12):1386-9. PubMed ID: 8968448
[TBL] [Abstract][Full Text] [Related]
5. The effect of fluvastatin of hyperlipidemia in renal transplant recipients: a prospective, placebo-controlled study.
Türk S; Yildiz A; Tükek T; Akkaya V; Aras U; Türkmen A; Uras AR; Sever MS
Int Urol Nephrol; 2001; 32(4):713-6. PubMed ID: 11989571
[TBL] [Abstract][Full Text] [Related]
6. Effect of fluvastatin for safely lowering atherogenic lipids in renal transplant patients receiving cyclosporine.
Holdaas H; Hartmann A; Stenstrøm J; Dahl KJ; Borge M; Pfister P
Am J Cardiol; 1995 Jul; 76(2):102A-106A. PubMed ID: 7604781
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.
Park JW; Siekmeier R; Lattke P; Merz M; Mix C; Schüler S; Jaross W
J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):351-61. PubMed ID: 11907637
[TBL] [Abstract][Full Text] [Related]
8. Effect of fluvastatin in combination with moderate endurance training on parameters of lipid metabolism.
Wittke R
Sports Med; 1999 May; 27(5):329-35. PubMed ID: 10368879
[TBL] [Abstract][Full Text] [Related]
9. Impact of fluvastatin on hyperlipidemia after renal transplantation.
Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
[TBL] [Abstract][Full Text] [Related]
10. Comparison of lipid-lowering effects of low-dose fluvastatin and conventional-dose gemfibrozil in patients with primary hypercholesterolemia.
Betteridge DJ; Durrington PN; Fairhurst GJ; Jackson G; McEwan MS; McInnes GT; Miller JP; Mir MA; Reckless JP; Rees-Jones DI
Am J Med; 1994 Jun; 96(6A):45S-54S. PubMed ID: 8017467
[TBL] [Abstract][Full Text] [Related]
11. Effects of alcohol and fluvastatin on lipid metabolism and hepatic function.
Smit JW; Wijnne HJ; Schobben F; Sitsen A; De Bruin TW; Erkelens DW
Ann Intern Med; 1995 May; 122(9):678-80. PubMed ID: 7702230
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and muscle safety of fluvastatin in cyclosporine-treated cardiac and renal transplant recipients: an exercise provocation test.
Schrama YC; Hené RJ; de Jonge N; Joles JA; Van Rijn HJ; Bär DR; Ververs TF; Van Tol A; Koomans HA
Transplantation; 1998 Nov; 66(9):1175-81. PubMed ID: 9825814
[TBL] [Abstract][Full Text] [Related]
13. Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects.
Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JL; Seman LJ; Ferrari A; Rubenstein JJ
Am J Cardiol; 2004 Jan; 93(1):31-9. PubMed ID: 14697462
[TBL] [Abstract][Full Text] [Related]
14. Effects of fluvastatin, a new inhibitor of HMG-CoA reductase, and niceritrol on serum lipids, lipoproteins and cholesterol ester transfer activity in primary hypercholesterolemic patients.
Sasaki J; Yamamoto K; Kobori S; Setoguchi Y; Sato Y; Matsunaga A; Shichiri M; Sakai T; Kono S; Arakawa K
Int J Clin Pharmacol Ther; 1995 Jul; 33(7):420-6. PubMed ID: 7582401
[TBL] [Abstract][Full Text] [Related]
15. A preliminary report of the safety and efficacy of fluvastatin for hypercholesterolemia in renal transplant patients receiving cyclosporine.
Goldberg RB; Roth D
Am J Cardiol; 1995 Jul; 76(2):107A-109A. PubMed ID: 7604782
[TBL] [Abstract][Full Text] [Related]
16. Comparison of lycopene and fluvastatin effects on atherosclerosis induced by a high-fat diet in rabbits.
Hu MY; Li YL; Jiang CH; Liu ZQ; Qu SL; Huang YM
Nutrition; 2008 Oct; 24(10):1030-8. PubMed ID: 18585898
[TBL] [Abstract][Full Text] [Related]
17. The effect of fluvastatin on parameters of bone remodeling.
Bjarnason NH; Riis BJ; Christiansen C
Osteoporos Int; 2001; 12(5):380-4. PubMed ID: 11444086
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin compared to fluvastatin in the reduction of serum lipids and apolipoproteins in patients with ischaemic heart disease and moderate hypercholesterolaemia.
Sigurdsson G; Haraldsdottir SO; Melberg TH; Tikkanen MJ; Miettinen TE; Kristianson KJ
Acta Cardiol; 1998; 53(1):7-14. PubMed ID: 9638964
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of fluvastatin in patients with non-insulin-dependent diabetes mellitus and hyperlipidemia.
Knopp RH; Frohlich J; Jokubaitis LA; Dawson K; Broyles FE; Gomez-Coronado D
Am J Med; 1994 Jun; 96(6A):69S-78S. PubMed ID: 8017470
[TBL] [Abstract][Full Text] [Related]
20. Comparative study between high-dose fluvastatin and low-dose fluvastatin and ezetimibe with regard to the effect on endothelial function in diabetic patients.
Kawagoe Y; Hattori Y; Nakano A; Aoki C; Tanaka S; Ohta S; Iijima T; Tomizawa A; Jojima T; Kase H; Kasai K
Endocr J; 2011; 58(3):171-5. PubMed ID: 21304215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
